Invivyd (IVVD) Other Non-Current Assets (2021 - 2025)
Invivyd (IVVD) posted Other Non-Current Assets of $110000.0 for Q4 2025, up 1733.33% on a QoQ basis from $6000.0 in Q3 2025, and up 223.53% year-over-year from $34000.0 in Q4 2024.
Invivyd (IVVD) Other Non-Current Assets (2021 - 2025) Analysis & Trends
Invivyd's Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $110000.0 for Q4 2025.
- Quarterly Other Non-Current Assets rose 223.53% year-over-year to $110000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $110000.0 (up 223.53% YoY) and the FY2025 annual result came in at $110000.0, up 223.53% from the prior year.
- Other Non-Current Assets was $110000.0 for Q4 2025 at Invivyd, up from $6000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $7.5 million in Q3 2024 and bottomed at $6000.0 in Q3 2025.
- A 5-year average of $1.3 million and a median of $236500.0 in 2022 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets surged 3885.03% — and 2025, when it sank 99.92%.
- Invivyd's Other Non-Current Assets stood at $3.3 million in 2021, then tumbled by 94.21% to $191000.0 in 2022, then fell by 8.38% to $175000.0 in 2023, then tumbled by 80.57% to $34000.0 in 2024, then soared by 223.53% to $110000.0 in 2025.
- Business Quant data shows IVVD's Other Non-Current Assets at $110000.0 in Q4 2025, $6000.0 in Q3 2025, and $15000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 60,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 104.24 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 14.48 Mn |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn | 110,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 110,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 15,000.00 |
| Mar 31, 2025 | 24,000.00 |
| Dec 31, 2024 | 34,000.00 |
| Sep 30, 2024 | 7.45 Mn |
| Jun 30, 2024 | 1.78 Mn |
| Mar 31, 2024 | 1.86 Mn |
| Dec 31, 2023 | 175,000.00 |
| Sep 30, 2023 | 187,000.00 |
| Jun 30, 2023 | 291,000.00 |
| Mar 31, 2023 | 291,000.00 |
| Dec 31, 2022 | 191,000.00 |
| Sep 30, 2022 | 236,000.00 |
| Jun 30, 2022 | 299,000.00 |
| Mar 31, 2022 | 237,000.00 |
| Dec 31, 2021 | 3.30 Mn |
| Sep 30, 2021 | 6.12 Mn |